1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsStipends available until funds are depleted; rolling/ongoing basis.
Lung Cancer Initiative Patient Emergency Fund is sponsored by Lung Cancer Initiative. Through the Patient Emergency Fund, Lung Cancer Initiative offers financial assistance to support lung cancer patients with healthy food costs, transportation, and other non-medical expenses related to emergencies associated with a lung cancer diagnosis.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Patient Programs | Lung Cancer Initiative Patient and Survivor Programs The access, care, and support you need Survivor Engagement Events Through the Patient Emergency Fund , Lung Cancer Initiative offers financial assistance to provide support for lung cancer patients to help with healthy food costs, transportation and other non-medical expenses to assist with emergencies associated with a lung cancer diagnosis.
Navigators fill out the online application. Patients contact your nurse navigator or download the application and bring it to your next appointment to fill out with a representative from your cancer center or have your cancer center fill out the online application. Follow the instructions on the application to return to LCI.
All questions must be answered in order to be considered for fulfillment. Email Molly Heym at mheym@lungcancerinitiative. org or call the LCI office at 919-784-0410 for assistance.
Applicants must be a resident of North Carolina. Applicants must currently be in treatment for lung cancer. Stipends are available until funds are depleted.
Each applicant can receive ONE STIPEND PER CALENDAR YEAR . Tomma Hargraves Gas Card Program The Lung Cancer Initiative Tomma Hargraves Gas Card Program provides assistance to lung cancer patients who are seeking treatment including clinical trials. The goal of the program is to lessen the financial burden for patients so they can receive appropriate lung cancer treatment by providing gas cards.
To be eligible for a gas card, the applicant must be a resident of North or South Carolina and currently undergoing treatment for lung cancer. An application must be completed and signed by both the applicant and the healthcare facility. Navigators fill out the online application.
Patients contact your nurse navigator or download the application and bring it to your next appointment to fill out with a representative from your cancer center or have your cancer center fill out the online application. Follow the instructions on the application to return to LCI. All questions must be answered in order to be considered for fulfillment.
Email Molly Heym at mheym@lungcancerinitiative. org or call the LCI office at 919-784-0410 for assistance. Applicants must be a resident of North or South Carolina.
Applicants must be currently in treatment for lung cancer. Applicants may apply once every four months to receive a $50. 00 gas card.
Each time an applicant applies, a new application must be filled out. “As a lung cancer survivor, I felt this need to find a tangible way to support patients on a very local level. It’s been gratifying to see how successful this gas card program has been at getting people to treatment.
” Questions about our gas card program? Interested in supporting this program? Contact Chief Mission Delivery Officer, Jenni Danai .
Survivor Engagement Events Survivor Engagement Events are programs designed to build a community of survivors who offer support and camaraderie to one another. Whether you were diagnosed yesterday or 20 years ago, you are welcome and encouraged to attend! Most of these events are social.
Occasionally, guest speakers or doctors will join and share relevant information for survivors. Each June, LCI hosts an annual Survivors Day Celebration for lung cancer survivors and their families. Meet and fellowship with other lung cancer survivors at our Online Survivor Luncheons which are on the second Tuesday of every month.
This is a perfect time for us to come together from across the state and socialize while we’re apart. View the luncheon dates and register here on Zoom. LCI offers an annual wellness retreat to provide lung cancer survivors with coping mechanisms proven to enhance quality of life after a lung cancer diagnosis.
We assemble a professional wellness team to provide survivors with evidence-based, integrative techniques to battle stress and tools to monitor their well-being. Most importantly, this retreat connects survivors to a community of others who truly understand what they are going through. This year, we will host our 9th annual Lung Cancer Survivor Wellness Retreat on September 18 – 20, 2026.
If you are interested in attending the retreat, please contact Cheryl Lecroy , Lung Cancer Initiative Survivor Liaison. Survivor Liaison – Cheryl Lecroy One of the primary goals of the Lung Cancer Initiative is to support patients in meeting their unique needs. If you or a loved one has been diagnosed with lung cancer, we encourage you to connect with Cheryl LeCroy, our Survivor Liaison, at CLecroy @LungCancerInitiative .
org . Cheryl is here to provide guidance and support every step of the way. Therapy Assistance Programs If you or a loved one needs help with paying for your treatment, consider the patient assistance program for the therapy you are taking.
Below are the patient assistance programs for approved lung cancer therapies. Lung cancer is at the forefront of AstraZeneca’s research and development focus. Our expanding portfolio aims to provide medicines that can improve outcomes at every stage of the disease.
But we know if we are to make meaningful progress for lung cancer patients, we cannot work alone. We have partnered with the International Association for the Study of Lung Cancer (IASLC), the Global Lung Cancer Coalition (GLCC), and Guardant Health to form the Lung Ambition Alliance.
Together we are taking urgent action to double five-year survival in lung cancer globally by 2025 – prioritising research and projects that increase screening, deliver innovative medicine and improve quality care For assistance with our program, please call our toll-free number Monday – Friday from 8:30 a. m. – 6:00 p.
m.
Eastern time: BI Cares Patient Assistance Program (includes several medicines) 1-800-556-8317 BI Cares Patient Assistance Program- Gilotrif 1-855-297-5904 BI Cares Patient Assistance Program- Ofev 1-855-297-5906 Lung Cancer Therapy: Gilotrif® and Ofev® In keeping with our commitment to do the most good for the most people, we work hard to ensure our medicines are accessible to patients, including senior citizens and families on limited incomes.
Through the BI Cares Foundation our Patient Assistance Program helps those in need obtain medications free of charge. Lung Cancer Therapy: Empliciti®, Nulojix ®, Onureg ®, Opdivo ® and Opdivo Combination, Orencia ®, Sprycel ®, Yervoy ® Support Center: 1-800-861-0048 8:00 a. m.
to 8:00 p. m. EST, Monday – Friday Bristol-Myers Squibb (BMS) is committed to helping patients get better access to their prescribed BMS medications.
That’s why we offer the BMS Access Support® program, which provides resources that help patients with their reimbursement challenges. Monday – Friday, 8:00 a. m.
– 10:00 p. m. EST Lung Cancer Therapies: ALIMTA® (pemetrexed for injection), CYRAMZA® (ramucirumab), Portrazza® (necitumumab), RetevmoTM (selpercatinib) Lilly TruAssist is the collection of Lilly patient assistance programs that offer assistance to help people obtain the Lilly medicines they need.
This site includes all of Lilly’s patient assistance programs with individual program details. Therapy: COSELA™ (trilaciclib) G1 to One™ Patient Support Program is here to help eligible patients who need COSELA™ (trilaciclib) gain access to it. We can help you with getting started on COSELA quickly, benefits investigations, out-of-pocket assistance, and getting COSELA for people who are uninsured for underinsured.
Lung Cancer Therapies: Avastin® (bevacizumab), ROZLYTREK™ (entrectinib), TECENTRIQ® (atezolizumab), ALECENSA® (alectinib), COTELLIC® (cobimetinib) Genentech Access Solutions is here to help when a Genentech medicine is prescribed. We offer a full range of programs and services to meet the needs of patients and health care professionals.
What patients need for access—from benefits investigations through patient assistance options—is available through Genentech Access Solutions. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization. JJPAF gives eligible patients free prescription medicines donated by Johnson & Johnson.
Patients may be eligible if they don’t have insurance, if their medicine is not covered by insurance, or if they have Medicare coverage and can’t pay for their medicine. Lung Cancer Therapy: Keytruda (pembrolizumab) The Merck Patient Assistance Program provides certain medicines free of charge to eligible patients. Lung Cancer Therapy: Zykadia® (ceritinib) http://www.
us. zykadia. com/patient/support.
jsp Co-pay assistance is available for eligible patients with a prescription for ZYKADIA. Monday – Friday, 9:00 a. m.
– 10:00 p. m. EST Lung Cancer Therapies: Tabrecta(capmatinib) The Novartis Patient Navigator Program is staffed by a team of specialists who are available to support you during your treatment journey.
Once enrolled in the program, you will receive a series of phone calls from a specially trained navigator who will help you understand the results of your benefits investigation, educate you about financial assistance options, and help you get started on your Novartis medicine(s).
Lung Cancer Therapy: Xalkori®(crizotinib) LORBRENA® (lorlatinib) VIZIMPRO® (dacomitinib) XALKORI® (crizotinib) VIZIMPRO® (dacomitinib) Pfizer RxPathways, formerly Pfizer Helpful Answers, is a comprehensive assistance program that provides eligible patients with a range of support services, including insurance counseling, co-pay assistance,* and access to medicines for free or at a savings.
Lung Cancer Therapy: EXKIVITY(mobocertinib) and ALUNBRIG(brigatinib) From finding financial assistance that may be right for you to understanding your disease, Takeda Oncology Here2Assist™ can provide the information you need throughout your treatment.
Virtual Reimbursement Resource NCCN Patient and Payment Assistance If your treatment is not listed, another resource is the National Comprehensive Cancer Network’s Virtual Reimbursement Resource Room, which aims to respond to the ever-evolving challenges for clinicians and others that work with patients with cancer.
Select a cancer or supportive care indication or select a reimbursement program to learn about reimbursement help and services available to you to help your practice mitigate reimbursement challenges. Did you know that survivors are able to attend LCI events for free? No registration fee required!
Check out our upcoming events and join us for a celebration of survivorship and to meet other survivors and families impacted by lung cancer Receiving a lung cancer diagnosis can be an overwhelming experience. LCI created the Peer-to-Peer Program so lung cancer patients would have ongoing support from a peer who has walked in their shoes. This program provides reciprocal support between lung cancer survivors.
Peers will share their experience and hopefully ease the stress, anxiety and fear that comes with a lung cancer diagnosis. Interested in becoming apart of the program? Contact Cheryl Lecroy.
According to the current listing, eligibility includes: North Carolina residents currently undergoing lung cancer treatment; one stipend per calendar year until funds are depleted. Confirm the full requirements in the official notice before applying.
Lung Cancer Initiative Patient Emergency Fund is funded by Lung Cancer Initiative. Verify program details on the funder's official page before applying.
This opportunity targets applicants in North Carolina. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article